These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS Life Sci; 2014 Jan; 95(1):29-39. PubMed ID: 24239644 [TBL] [Abstract][Full Text] [Related]
11. CD19+ in intestinal mucosa predict the response to infliximab in Crohn's disease. Ferkolj I; Ihan A; Markovic S Hepatogastroenterology; 2005; 52(64):1128-33. PubMed ID: 16001645 [TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide inhibits adhesion molecule expression in activated human colon serosal fibroblasts by preventing NF-kappaB activation. Tao Q; Ren J; Li J J Surg Res; 2007 Jun; 140(1):84-9. PubMed ID: 17275031 [TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q; Hogezand RA; Lamers CB; Verspaget HW Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling. Liu C; Dunkin D; Lai J; Song Y; Ceballos C; Benkov K; Li XM Inflamm Bowel Dis; 2015 Aug; 21(8):1918-25. PubMed ID: 25993687 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of mucosal TNF-alpha transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapy. Schmidt C; Giese T; Hermann E; Zeuzem S; Meuer SC; Stallmach A Inflamm Bowel Dis; 2007 Jan; 13(1):65-70. PubMed ID: 17206641 [TBL] [Abstract][Full Text] [Related]
16. Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease. Agnholt J; Dahlerup JF; Buntzen S; Tøttrup A; Nielsen SL; Lundorf E Aliment Pharmacol Ther; 2003 Mar; 17(5):703-10. PubMed ID: 12641520 [TBL] [Abstract][Full Text] [Related]
17. The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease. Stio M; Martinesi M; Bruni S; Treves C; Mathieu C; Verstuyf A; d'Albasio G; Bagnoli S; Bonanomi AG J Steroid Biochem Mol Biol; 2007 Jan; 103(1):51-60. PubMed ID: 17049230 [TBL] [Abstract][Full Text] [Related]
18. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha. Dichamp I; Bourgeois A; Dirand C; Herbein G; Wendling D J Rheumatol; 2007 Oct; 34(10):1976-83. PubMed ID: 17896809 [TBL] [Abstract][Full Text] [Related]
19. Early changes in rectal nitric oxide and mucosal inflammatory mediators in Crohn's colitis in response to infliximab treatment. Ljung T; Axelsson LG; Herulf M; Lundberg JO; Hellström PM Aliment Pharmacol Ther; 2007 Apr; 25(8):925-32. PubMed ID: 17402996 [TBL] [Abstract][Full Text] [Related]
20. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. ten Hove T; van Montfrans C; Peppelenbosch MP; van Deventer SJ Gut; 2002 Feb; 50(2):206-11. PubMed ID: 11788561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]